Profil
Toshihiro Maeda is currently the Chief Operating Officer & Executive Vice President at Nxera Pharma Co., Ltd. He previously worked at Bristol Myers Squibb Co. as the Head-Cell Therapy.
Mr. Maeda holds an MBA from The University of Chicago Booth School of Business.
Postes actifs de Toshihiro Maeda
| Sociétés | Poste | Début |
|---|---|---|
| NXERA PHARMA CO., LTD. | Directeur des opérations | 01/12/2023 |
Anciens postes connus de Toshihiro Maeda
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formation de Toshihiro Maeda
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Nxera Pharma Co., Ltd.
Nxera Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceutical products | Health Technology |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















